Guidelines for the management of adult myelodysplastic syndromes

被引:17
|
作者
Killick, Sally B. [1 ]
Ingram, Wendy [2 ]
Culligan, Dominic [3 ]
Enright, Helen [4 ]
Kell, Jonathan [2 ]
Payne, Elspeth M. [5 ]
Krishnamurthy, Pramila [6 ]
Kulasekararaj, Austin [6 ]
Raghavan, Manoj [7 ]
Stanworth, Simon J. [8 ,9 ]
Green, Simone [10 ]
Mufti, Ghulam [6 ]
Quek, Lynn [6 ]
Cargo, Catherine [11 ]
Jones, Gail L. [12 ]
Mills, Juliet [13 ,14 ]
Sternberg, Alex [15 ]
Wiseman, Daniel H. [16 ]
Bowen, David [11 ]
机构
[1] Univ Hosp Dorset NHS Fdn Trust, Royal Bournemouth Hosp, Bournemouth, Dorset, England
[2] Univ Hosp Wales, Cardiff, Wales
[3] Aberdeen Royal Infirm, Aberdeen, Scotland
[4] Trinity Coll Dublin, Tallaght Univ Hosp, Med Sch, Dublin, Ireland
[5] UCL, Canc Inst, London, England
[6] Kings Coll Hosp NHS Fdn Trust, London, England
[7] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England
[8] Univ Oxford, Oxford Univ Hosp NHS Trust, Oxford, England
[9] NHS Blood & Transplant, Oxford, England
[10] Hull & East Yorkshire Hosp NHS Trust, Kingston Upon Hull, N Humberside, England
[11] Leeds Teaching Hosp, St Jamess Inst Oncol, Leeds, W Yorkshire, England
[12] Newcastle Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England
[13] Worcestershire Acute Hosp NHS Trust, Worcester, England
[14] Birmingham NHS Fdn Trust, Worcester, England
[15] Great Western Hosp NHS Fdn Trust, Swindon, Wilts, England
[16] Christie NHS Fdn Trust, Manchester, Lancs, England
关键词
myelodysplastic syndromes; MDS; guideline; management; STEM-CELL TRANSPLANTATION; ACUTE MYELOID-LEUKEMIA; TRANSFUSION-DEPENDENT PATIENTS; CONVENTIONAL CARE REGIMENS; PROGNOSTIC SCORING SYSTEM; COLONY-STIMULATING FACTOR; IRON CHELATION-THERAPY; RANDOMIZED PHASE-III; LABILE PLASMA IRON; RISK MDS PATIENTS;
D O I
10.1111/bjh.17612
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:267 / 281
页数:15
相关论文
共 50 条
  • [31] Personalized treatment strategies for elderly patients with myelodysplastic syndromes
    Castelli, Roberto
    Bergamaschini, Luigi
    Schiavon, Riccardo
    Lambertenghi-Deliliers, Giorgio
    EXPERT REVIEW OF HEMATOLOGY, 2017, 10 (12) : 1077 - 1086
  • [32] Myelodysplastic Syndromes: Diagnosis and Treatment
    Steensma, David P.
    MAYO CLINIC PROCEEDINGS, 2015, 90 (07) : 969 - 983
  • [33] MANAGEMENT OF MYELODYSPLASTIC SYNDROMES IN ADULTS: GUIDELINES FROM THE BELGIAN HAEMATOLOGICAL SOCIETY
    Meers, S.
    Breems, D.
    Bries, G.
    Delforge, M.
    Graux, C.
    Ravoet, C.
    Selleslag, D.
    Noens, L.
    ACTA CLINICA BELGICA, 2013, 68 (04) : 253 - 262
  • [34] Myelodysplastic Syndromes
    Greenberg, Peter L.
    Attar, Eyal
    Bennett, John M.
    Bloomfield, Clara D.
    De Castro, Carlos M.
    Deeg, H. Joachim
    Foran, James M.
    Gaensler, Karin
    Garcia-Manero, Guillermo
    Gore, Steven D.
    Head, David
    Komrokji, Rami
    Maness, Lori J.
    Millenson, Michael
    Nimer, Stephen D.
    O'Donnell, Margaret R.
    Schroeder, Mark A.
    Shami, Paul J.
    Stone, Richard M.
    Thompson, James E.
    Westervelt, Peter
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2011, 9 (01): : 30 - 56
  • [35] Management of myelodysplastic syndromes
    Duchmann, Matthieu
    Fenaux, Pierre
    Cluzeau, Thomas
    BULLETIN DU CANCER, 2015, 102 (11) : 946 - 957
  • [36] Novel agents for the management of myelodysplastic syndromes
    Meletis, John
    Viniou, Nora
    Terpos, Evangelos
    MEDICAL SCIENCE MONITOR, 2006, 12 (09): : RA194 - RA206
  • [37] Management of lower-risk myelodysplastic syndromes without del5q: current approach and future trends
    Stahl, Maximilian
    Zeidan, Amer M.
    EXPERT REVIEW OF HEMATOLOGY, 2017, 10 (04) : 345 - 364
  • [38] Epidemiology of myelodysplastic syndromes: Why characterizing the beast is a prerequisite to taming it
    Zeidan, Amer M.
    Shallis, Rory M.
    Wang, Rong
    Davidoff, Amy
    Ma, Xiaomei
    BLOOD REVIEWS, 2019, 34 : 1 - 15
  • [39] How I treat myelodysplastic syndromes
    Zhao, Lin-Pierre
    Sebert, Marie
    HEMATOLOGIE, 2023, 29 (05): : 303 - 315
  • [40] Management of myelodysplastic syndromes after failure of response to hypomethylating agents
    Gil-Perez, Angela
    Montalban-Bravo, Guillermo
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2019, 10 : 1 - 18